These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9005797)

  • 21. [Efficacy of lomefloxacin in treatment of nonspecific inflammatory diseases and in prophylaxis of postoperative complications in urology].
    Derevianko II; Khodyreva LA; Avdoshin VL; Andriukhin MI; Gabliia MIu
    Antibiot Khimioter; 1998; 43(10):36-41. PubMed ID: 9825109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [An attempt to use ofloxacin in patients with mucoviscidosis].
    Chuchalin AG; Sokolov AS; Apul'tsina ID; GUgutsidze EN; Kuchkina NV; Samsonova MV
    Antibiot Khimioter; 1996; 41(9):43-6. PubMed ID: 9005785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single dose of ofloxacin treatment in women with dysuria and frequency.
    Simşek F; Dillioğlugil O; Ilker Y; Akdaş A
    Int Urol Nephrol; 1993; 25(3):249-54. PubMed ID: 8225825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of clinical efficacy of antimicrobials in complicated urinary tract infections. Comparison of Japanese criteria with IDSA guidelines. Infectious Diseases Society of America.
    Kawada Y; Lee SE; Chen C; Limson BM; Chan P; Kongkanand A; Wudhikarn S; Tung KH; Rahardjo P; Saito I
    Drugs; 1995; 49 Suppl 2():362-4. PubMed ID: 8549363
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapeutic potential of ofloxacin in hospital medicine. A French multicenter study].
    Carbon C; Delval C
    Pathol Biol (Paris); 1990 May; 38(5):397-400. PubMed ID: 2195449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Drugs Exp Clin Res; 1987; 13(9):555-61. PubMed ID: 3480796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ofloxacin treatment in nephrologic problem patients with various degrees of chronic renal failure (including dialysis treatment). Preliminary results].
    Schulz W; Dörfler A
    Infection; 1986; 14 Suppl 1():S97-101. PubMed ID: 3456988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter open-label study of parenteral ofloxacin in treatment of pyelonephritis in adults.
    Cox CE; Gentry LO; Rodriguez-Gomez G
    Urology; 1992 May; 39(5):453-6. PubMed ID: 1580038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ofloxacin: new applications for the prevention of urinary tract infections in renal graft recipients.
    Rafat C; Vimont S; Ancel PY; Xu-Dubois YC; Mesnard L; Ouali N; Denis M; Vandewalle A; Rondeau E; Hertig A
    Transpl Infect Dis; 2011 Aug; 13(4):344-52. PubMed ID: 21299776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of experimental bacterial keratitis with topical trovafloxacin.
    Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
    Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ofloxacin in the comprehensive therapy of complicated forms of wound infection].
    Blatun LA; Iakovlev VP; Elagina LV
    Antibiot Khimioter; 1994 Jan; 39(1):33-7. PubMed ID: 8060193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [An attempt to use ofloxacin in the treatment of acute intestinal infections].
    Lobzin IuV
    Antibiot Khimioter; 1996; 41(9):96-8. PubMed ID: 9005799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ofloxacin in urinary tract infections.
    Kromann-Andersen B; Krøyer Nielsen K
    Scand J Infect Dis Suppl; 1990; 68():35-40. PubMed ID: 2218420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of ofloxacin in open fractures and in the treatment of post-traumatic osteomyelitis.
    Ketterl R; Beckurts T; Stübinger B; Claudi B
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():159-66. PubMed ID: 3053576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG; Woods GL; Jiang Q; Gesser RM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO; Izard D; Bryskier A; Leclerc H
    Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Why not performing susceptibility test for trimethoprim-sulphamethoxazole?
    Hagiya H
    J Chemother; 2015 Feb; 27(2):124-5. PubMed ID: 25248022
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antibacterial activity of ofloxacin in urine for 4 days after a single oral dose of 400 mg].
    Guibert J; Kitzis MD; Acar JF
    Pathol Biol (Paris); 1998 Oct; 46(8):656-60. PubMed ID: 9871938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quinolones for short-term treatment of uncomplicated urinary tract infection.
    Kadiri S; Ajayi SO; Toki RA
    East Afr Med J; 1999 Oct; 76(10):587-9. PubMed ID: 10734512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.